Home/Filings/4/0001209191-19-005265
4//SEC Filing

Robinson Gregory Scott 4

Accession 0001209191-19-005265

CIK 0001711675other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 9:04 PM ET

Size

5.8 KB

Accession

0001209191-19-005265

Insider Transaction Report

Form 4
Period: 2019-01-22
Robinson Gregory Scott
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-01-22+91,40091,400 total
    Exercise: $14.74Exp: 2029-01-21Ordinary Shares (91,400 underlying)
Footnotes (2)
  • [F1]This option will vest as to 25% on January 1, 2020. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.
  • [F2]The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.

Issuer

Nightstar Therapeutics plc

CIK 0001711675

Entity typeother

Related Parties

1
  • filerCIK 0001761163

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 9:04 PM ET
Size
5.8 KB